A major breakthrough in the understanding and future control of deadly cholera epidemics
In a report publishing October 17th, 2013 in PLOS Neglected Tropical Diseases, the international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) and its scientific research arm, Epicentre, present results of one of the first-ever, large-scale use of an oral cholera vaccine during a cholera outbreak — a major breakthrough in the understanding and future control of deadly cholera epidemics.
Using results from a mass vaccination campaign of more than 300,000 people conducted in Guinea last year, MSF and Epicentre show the feasibility of implementing a mass vaccination campaign with oral cholera at the onset of an outbreak, similar to the way reactive vaccination campaigns are conducted when diseases such as measles or meningitis are reported in an area.
Last year, MSF teams in Guinea noticed cases of cholera months ahead of the rainy season. These early cholera cases and other factors, including the lack of a cholera epidemic in Guinea for several years, and the ongoing cholera epidemic in neighboring Sierra Leone, were strong indications to MSF and the Ministry of Health that a major cholera epidemic was imminent.
Starting in April of last year the Guinean Ministry of Health and MSF administered 316,250 doses of vaccine during two vaccination rounds in the coastal districts of Boffa and Forecariah, Guinea over six weeks. All individuals older than 12 months were eligible for vaccination in both rounds. The vaccination campaign was well accepted by the local community and MSF achieved high coverage rates. The two doses vaccine coverage was 75.8% in Boffa and 75.9% in Forecariah, respectively. Almost all people surveyed after the campaign, 98.9 percent, reported that they would be vaccinated again in a future cholera campaign.
Oral cholera vaccine was added to the WHO recommendation for cholera treatment in 2010, but so far has not been commonly used as a public health tool for control of the disease. Concerns about its feasibility, timeliness and acceptability by population, as well as fear of diverting resources from other medical programs have discouraged the use of an oral cholera vaccine.
The Latest on: Oral Cholera Vaccine
- Google's Artificial Intelligence Hate Speech Detector Is Racially Biasedon August 13, 2019 at 8:52 am
Google recently created an artificial intelligence algorithm ... or ideological biases. Many AI systems will continue to be trained using bad data, making this an ongoing problem. But we believe that ...
- How Bias Distorts AI (Artificial Intelligence)on August 4, 2019 at 9:55 am
When it comes to AI (Artificial Intelligence), there's usually a major focus on ... So here's a look at what she has to say about bias: Can you share some real-life examples of bias in AI systems and ...
- New AI tool seeks to eliminate racial bias in prosecutionson July 26, 2019 at 12:50 pm
San Francisco District Attorney George Gascon recently announced a new artificial intelligence tool that will automatically ... He wants to eliminate any influence of racial bias in the ...
- Government Should Address Potential Bias in Artificial Intelligence, Lawmakers Sayon July 24, 2019 at 12:47 pm
Bias in artificial intelligence could critically impact the deployment ... then we shouldn't have a black box sort of AI system,” Heinrich said. He explained that when it comes to using AI and machine ...
- How to Avoid Bias in Your AI Implementationon July 9, 2019 at 7:07 am
When it comes to artificial intelligence, the bias of those who program the ... IBM has launched a software service that looks for bias in AI systems and determines why automated decisions were made.
via Google News and Bing News